Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition

Published:2014-04-16 Issue:4 Volume:9 Page:e92546
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Minata Mutsuko,Gu Chunyu,Joshi Kaushal,Nakano-Okuno Mariko,Hong Christopher,Nguyen Chi-Hung,Kornblum Harley I.,Molla Annie,Nakano Ichiro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation;AN Filiano;Radiat Res,2011

2. Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome;JM Grunda;Clin Cancer Res,2010

3. Brain tumor stem cells;E Sulman;Curr Probl Cancer,2008

4. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;S Bao;Nature,2006

5. Glioma formation, cancer stem cells, and akt signaling;D Hambardzumyan;Stem Cell Rev,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting MELK in tumor cells and tumor microenvironment: from function and mechanism to therapeutic application;Clinical and Translational Oncology;2024-08-26

2. The Effect of Therapy Regimen on Antitumor Efficacy of the Nanosomal Doxorubicin against Rat Glioblastoma 101.8;Bulletin of Experimental Biology and Medicine;2024-03

3. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity;Cancer Letters;2023-04

4. Structural classification of MELK inhibitors and prospects for the treatment of tumor resistance: A review;Biomedicine & Pharmacotherapy;2022-12

5. MELK is a prognostic biomarker and correlated with immune infiltration in glioma;Frontiers in Neurology;2022-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3